No its not what the 4C says but how on earth is 45 qtrs (11 yrs) of funding available? LOL The amazing cost-cutting has worked wonders, but cut to $113k this qtr... is that sustainable?... probably not, but lets revel in no CR for quite some time, at least. Well done, Rebecca and the team! At least the shackles around this company's stock price can be cut loose now.
- Forums
- ASX - By Stock
- CHM
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $69.39K | 17.34M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 9208291 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.003 |
16 | 13800507 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 9208291 | 9 |
0.005 | 14791167 | 23 |
0.006 | 13747410 | 16 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
Last trade - 11.21am 18/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online